308 related articles for article (PubMed ID: 34112203)
1. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19.
Tan Q; He L; Meng X; Wang W; Pan H; Yin W; Zhu T; Huang X; Shan H
J Nanobiotechnology; 2021 Jun; 19(1):173. PubMed ID: 34112203
[TBL] [Abstract][Full Text] [Related]
2. Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment.
Witika BA; Makoni PA; Mweetwa LL; Ntemi PV; Chikukwa MTR; Matafwali SK; Mwila C; Mudenda S; Katandula J; Walker RB
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339110
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
4. Macrophage Membrane-Derived Biomimetic Nanoparticles for Treatment of Cytokine Release Syndrome.
Jiang H; Tai Z; Pan H; Cui Z; Chai R; Zhu C; Tian J; Bao L; Zhu Q; Chen Z
J Biomed Nanotechnol; 2022 Apr; 18(4):1064-1074. PubMed ID: 35854441
[TBL] [Abstract][Full Text] [Related]
5. Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19.
Zarei M; Sahebi Vaighan N; Ziai SA
Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):633-643. PubMed ID: 34647511
[TBL] [Abstract][Full Text] [Related]
6. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence.
Mohanty RR; Padhy BM; Das S; Meher BR
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2802-2807. PubMed ID: 33829465
[TBL] [Abstract][Full Text] [Related]
8. Phytotherapy for treatment of cytokine storm in COVID-19.
Sapra L; Bhardwaj A; Azam Z; Madhry D; Verma B; Rathore S; Srivastava RK
Front Biosci (Landmark Ed); 2021 Apr; 26(5):51-75. PubMed ID: 34027650
[TBL] [Abstract][Full Text] [Related]
9. Potential health benefits of zinc supplementation for the management of COVID-19 pandemic.
Oyagbemi AA; Ajibade TO; Aboua YG; Gbadamosi IT; Adedapo ADA; Aro AO; Adejumobi OA; Thamahane-Katengua E; Omobowale TO; Falayi OO; Oyagbemi TO; Ogunpolu BS; Hassan FO; Ogunmiluyi IO; Ola-Davies OE; Saba AB; Adedapo AA; Nkadimeng SM; McGaw LJ; Kayoka-Kabongo PN; Oguntibeju OO; Yakubu MA
J Food Biochem; 2021 Feb; 45(2):e13604. PubMed ID: 33458853
[TBL] [Abstract][Full Text] [Related]
10. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
Marzolini C; Stader F; Stoeckle M; Franzeck F; Egli A; Bassetti S; Hollinger A; Osthoff M; Weisser M; Gebhard CE; Baettig V; Geenen J; Khanna N; Tschudin-Sutter S; Mueller D; Hirsch HH; Battegay M; Sendi P
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32641296
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
Dzobo K; Chiririwa H; Dandara C; Dzobo W
OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases.
Ou AT; Zhang JX; Fang YF; Wang R; Tang XP; Zhao PF; Zhao YG; Zhang M; Huang YZ
Acta Pharmacol Sin; 2021 Nov; 42(11):1913-1920. PubMed ID: 34561552
[TBL] [Abstract][Full Text] [Related]
13. Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced "cytokines storm".
Giuliani C; Bucci I; Napolitano G
Med Hypotheses; 2021 Jan; 146():110473. PubMed ID: 33385879
[TBL] [Abstract][Full Text] [Related]
14. Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients.
Stader F; Battegay M; Sendi P; Marzolini C
Clin Pharmacol Ther; 2022 Mar; 111(3):579-584. PubMed ID: 34496043
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.
Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C
Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538
[TBL] [Abstract][Full Text] [Related]
16. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.
Amere Subbarao S
Inflammopharmacology; 2021 Apr; 29(2):343-366. PubMed ID: 33723711
[TBL] [Abstract][Full Text] [Related]
17. Structure-aided ACEI-capped remdesivir-loaded novel PLGA nanoparticles: toward a computational simulation design for anti-SARS-CoV-2 therapy.
Wu J; Wang H; Li B
Phys Chem Chem Phys; 2020 Dec; 22(48):28434-28439. PubMed ID: 33305304
[TBL] [Abstract][Full Text] [Related]
18. A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2.
Ucar B; Acar T; Arayici PP; Derman S
Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34375967
[TBL] [Abstract][Full Text] [Related]
19. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
[TBL] [Abstract][Full Text] [Related]
20. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]